130 related articles for article (PubMed ID: 8399532)
1. Simultaneous monitoring of levodopa, dopamine and their metabolites in skeletal muscle and subcutaneous tissue in different pharmacological conditions using microdialysis.
Deleu D; Sarre S; Ebinger G; Michotte Y
J Pharm Biomed Anal; 1993 Jul; 11(7):577-85. PubMed ID: 8399532
[TBL] [Abstract][Full Text] [Related]
2. The effect of carbidopa on the pharmacokinetics and metabolism of intravenously administered levodopa in blood plasma and skeletal muscle.
Deleu D; Sarre S; Ebinger G; Michotte Y
Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):576-81. PubMed ID: 8133901
[TBL] [Abstract][Full Text] [Related]
3. The effect of carbidopa and entacapone pretreatment on the L-dopa pharmacokinetics and metabolism in blood plasma and skeletal muscle in beagle dog: an in vivo microdialysis study.
Deleu D; Sarre S; Ebinger G; Michotte Y
J Pharmacol Exp Ther; 1995 Jun; 273(3):1323-31. PubMed ID: 7791104
[TBL] [Abstract][Full Text] [Related]
4. The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to rats.
Rose S; Jenner P; Marsden CD
Mov Disord; 1988; 3(2):117-25. PubMed ID: 3221899
[TBL] [Abstract][Full Text] [Related]
5. Circadian phase dependent pharmacokinetics of L-dopa, its main metabolites (3-OMD, HVA, DOPAC) and carbidopa in rats.
Andre MH; Grignon S; Bruguerolle B
Fundam Clin Pharmacol; 1996; 10(4):350-5. PubMed ID: 8871134
[TBL] [Abstract][Full Text] [Related]
6. Quantitative microdialysis for studying the in vivo L-DOPA kinetics in blood and skeletal muscle of the dog.
Sarre S; Deleu D; Van Belle K; Ebinger G; Michotte Y
Pharm Res; 1995 May; 12(5):746-50. PubMed ID: 7479562
[TBL] [Abstract][Full Text] [Related]
7. Peripheral pharmacokinetic handling and metabolism of L-dopa in the rat: the effect of route of administration and carbidopa pretreatment.
Rose S; Jenner P; Marsden CD
J Pharm Pharmacol; 1991 May; 43(5):325-30. PubMed ID: 1680174
[TBL] [Abstract][Full Text] [Related]
8. Chronic administration does not alter the accumulation of L-dopa into muscle.
Rose S; Jenner P; Marsden CD
Mov Disord; 1994 Mar; 9(2):167-72. PubMed ID: 8196677
[TBL] [Abstract][Full Text] [Related]
9. In vivo pharmacokinetics of levodopa and 3-O-methyldopa in muscle. A microdialysis study.
Deleu D; Sarre S; Ebinger G; Michotte Y
Naunyn Schmiedebergs Arch Pharmacol; 1991 Nov; 344(5):514-9. PubMed ID: 1811168
[TBL] [Abstract][Full Text] [Related]
10. In vivo microdialysis to determine the relative pharmacokinetics of drugs.
Nakashima M; Zhao MF; Nakashima MN; Sakurai M; Sasaki H; Matsuyama K; Ichikawa M
Biol Pharm Bull; 1996 Jul; 19(7):988-94. PubMed ID: 8839975
[TBL] [Abstract][Full Text] [Related]
11. Continuous intravenous monitoring of levodopa and 3-O-methyldopa by microdialysis and high-performance liquid chromatography with electrochemical detection.
Deleu D; Sarre S; Herregodts P; Ebinger G; Michotte Y
J Pharm Biomed Anal; 1991; 9(2):159-65. PubMed ID: 1873307
[TBL] [Abstract][Full Text] [Related]
12. Modified high-performance liquid chromatography with electrochemical detection method for plasma measurement of levodopa, 3-O-methyldopa, dopamine, carbidopa and 3,4-dihydroxyphenyl acetic acid.
Karimi M; Carl JL; Loftin S; Perlmutter JS
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 836(1-2):120-3. PubMed ID: 16584928
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two new inhibitors of catechol O-methylation on striatal dopamine metabolism: a microdialysis study in rats.
Törnwall M; Kaakkola S; Tuomainen P; Kask A; Männistö PT
Br J Pharmacol; 1994 May; 112(1):13-8. PubMed ID: 7518301
[TBL] [Abstract][Full Text] [Related]
14. Microdialysis studies on the action of tolcapone on pharmacologically-elevated extracellular dopamine levels in conscious rats.
Huotari M; Gainetdinov R; Männistö PT
Pharmacol Toxicol; 1999 Nov; 85(5):233-8. PubMed ID: 10608486
[TBL] [Abstract][Full Text] [Related]
15. Detection of levodopa, dopamine and its metabolites in rat striatum dialysates following peripheral administration of L-DOPA prodrugs by mean of HPLC-EC.
Cannazza G; Di Stefano A; Mosciatti B; Braghiroli D; Baraldi M; Pinnen F; Sozio P; Benatti C; Parenti C
J Pharm Biomed Anal; 2005 Jan; 36(5):1079-84. PubMed ID: 15620535
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous high-performance liquid chromatographic analysis of carbidopa, levodopa and 3-O-methyldopa in plasma and carbidopa, levodopa and dopamine in urine using electrochemical detection.
Titus DC; August TF; Yeh KC; Eisenhandler R; Bayne WF; Musson DG
J Chromatogr; 1990 Dec; 534():87-100. PubMed ID: 2094725
[TBL] [Abstract][Full Text] [Related]
17. Effects of tolcapone, a novel catechol-O-methyltransferase inhibitor, on striatal metabolism of L-dopa and dopamine in rats.
Napolitano A; Zürcher G; Da Prada M
Eur J Pharmacol; 1995 Feb; 273(3):215-21. PubMed ID: 7737328
[TBL] [Abstract][Full Text] [Related]
18. High-performance liquid chromatography with electrochemical detection for the determination of levodopa, catecholamines and their metabolites in rat brain dialysates.
Sarre S; Michotte Y; Herregodts P; Deleu D; De Klippel N; Ebinger G
J Chromatogr; 1992 Mar; 575(2):207-12. PubMed ID: 1629296
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of carbidopa on hydroxyl radical generation in the rat striatum by dopamine.
Obata T; Yamanaka Y
Neurosci Lett; 1996 Dec; 221(1):13-6. PubMed ID: 9014169
[TBL] [Abstract][Full Text] [Related]
20. Assessment of dopamine and its metabolites in the intracellular and extracellular compartments of the rat striatum after peripheral administration of L-[11C]dopa.
Miwa S; Gillberg PG; Bjurling P; Yumoto N; Odano I; Watanabe Y; Långström B
Brain Res; 1992 Apr; 578(1-2):122-8. PubMed ID: 1511268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
